2025-04-10T13:07:35-05:00 2024-12-31 991856619 GRANT THORNTON ADVISORS LLC 757 THIRD AVENUE 3RD FLOOR NEW YORK NY 100172013 990PF 2024-01-01 463285474 CLINICAL RESEARCH ASSOCIATES LLC CLIN 6466540066 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 MARLOW KEE TREASURER 6466540066 2025-04-10 1 1 SCOTT THOMPSETT P00741490 2125990100 2024 2025-03-06 01:10:19Z X 1370045 X 4227515 5500 5500 5500 0 0 4233015 5500 5500 0 0 0 0 694261 0 0 694261 215822 0 0 215822 106928 0 0 98446 4770 0 0 4770 2524 0 0 2350 36000 0 0 36000 12085 0 0 12085 2598111 5500 5500 2908074 3670501 5500 5500 3971808 200000 200000 3870501 5500 5500 4171808 362514 0 0 410222 473841 473841 106936 112436 112436 633095 629078 629078 268627 154690 154690 1418880 1370045 1370045 594657 197067 65659 51900 660316 248967 X 758564 1121078 758564 1121078 1418880 1370045 758564 362514 0 1121078 0 1121078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 DE NY 1 1 0 0 0 1 N/A MARLOW KEE 6466540066 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 KELSEY MARTIN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 PRESIDENT/MANAGER 1.00 0 0 0 DAVID SPERGEL 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 CHAIRPERSON/MANAGER 1.00 0 0 0 EUAN ROBERTSON 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 VICE PRESIDENT 1.00 0 0 0 MARLOW KEE 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 TREASURER/MANAGER 1.00 0 0 0 BRETT DAKIN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 SECRETARY 1.00 0 0 0 PAUL WANG 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 DIRECTOR OF CRA 40.00 430453 84606 0 KAREN WALTON-BOWEN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 DIRECTOR OF CLINICAL 40.00 263808 57022 0 0 PEACHTREE BIORESEARCH SOLUTIONS 4985 LOWER ROSWELL RD BLDG 100 MARIETTA GA 30068 RESEARCH 1577635 PROFESSIONAL CASE MGMT CLINICAL TRIALS LLC 500 E 8TH AVE DENVER CO 80203 RESEARCH 81478 COOLEY LLP 3 EMBARCADERO CENTER 20TH FLR SAN FRANCISCO CA 94111 LEGAL 78226 0 AUTISM RESEARCH - CRA'S IMMEDIATE AIM IS TO EVALUATE ARBACLOFEN (R-BACLOFEN, STX209), AN EXPERIMENTAL MEDICATION, AS A POTENTIAL THERAPY IN ASD AND RELATED CONDITIONS. 3819630 0 0 802832 0 802832 0 0 802832 12042 790790 39540 X 4171808 0 4171808 2015-07-27 X 0 4965 1124 52 6141 0 4220 955 44 5220 4171808 3284681 2091505 1578734 11126728 200000 0 0 44758 244758 3971808 3284681 2091505 1533976 10881970 0 0 26360 20830 18835 12569 78594 0 0 0 0 X THE CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE 3401 CIVIC CENTER BLVD PHILADELPHIA PA 19104 N/A PC COMPUTER VISION BASED PHENOTYPING OF 16P11.2 ARBACLOFEN DOUBLE BLIND PLACEBO CONTROLLED STUDY. 200000 200000 0 14 5500 0 5500 0 5500 0 0 0 0 0 0 0 0 0 0 X X 1 THE SIMONS FOUNDATION 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 4227515 X TAX PREPARATION FEES 4770 0 0 4770 PART I, LINE 23 & PART II, LINE 15 PATENT AMORTIZATION EXPENSE DATE ACQUIRED 1/1/2014PATENT ORIGINAL VALUE $1,000,000 2024 AMORTIZATION $(84,531) DEDUCTION IN PRIOR YEARS $(760,779) ------------TOTAL AMORTIZATION $(845,310) ------------PATENT NET VALUE $154,690 ------------ ------------ COOLEY LLP 86707 0 0 78226 FOX ROTHSCHILD LLP 19624 0 0 19624 LOEB, BLOCK & PARTNERS LLP 597 0 0 596 INTANGIBLE ASSET (R&D) 239221 154690 154690 DUE FROM THIRD PARTIES 29406 0 0 PHARMACEUTICAL RESEARCH 1655210 0 0 2042837 DIRECT PROGRAM 722902 0 0 730779 ADMINISTRATIVE 95292 5500 5500 94292 PATENT AMORTIZATION 84531 0 0 0 INFORMATION TECHNOLOGY 20198 0 0 20205 CLINICAL TRIAL INSURANCE 17234 0 0 17234 EMPLOYEE DEVELOPMENT 2744 0 0 2727 DUE TO THE SIMONS FOUNDATION 65659 51900 HUMAN RESOURCES CONSULTING 2238 0 0 2064 MISC. PROFESSIONAL SERVICES 286 0 0 286